Tag: Glucagon-like peptide-1 receptor agonist
Is Semaglutide the ‘New Statin’? Not So Fast
Is Semaglutide the Breakthrough Treatment for Obesity and Cardiovascular Disease?
There has been much excitement surrounding the results of the SELECT cardiovascular outcomes trial (CVOT) presented at this year's European Congress on Obesity, with many...
